Wolverine Trading, LLC Amicus Therapeutics, Inc. Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 59,772 shares of FOLD stock, worth $585,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,772

Previous 16,200 268.96%

Holding current value

$585,765

Previous $160,000 298.75%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $570,822 - $722,643	59,772 New	59,772 $638,000
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $112,776 - $139,962	10,337 New	10,337 $113,000
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $165,841 - $224,664	-18,975 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$8.71 - $10.72 $209,336 - $257,644	-24,034 Reduced 55.88%	18,975 $189,000
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $288,696 - $748,726	31,380 Added 269.84%	43,009 $404,000
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $2,990 - $5,525	222 Added 1.95%	11,629 $267,000
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $15,390 - $18,972	1,194 Added 11.69%	11,407 $161,000
Q2 2020 Aug 13, 2020	SELL	$8.86 - $15.69 $2,064 - $3,655	-233 Reduced 2.23%	10,213 $159,000
Q1 2020 May 11, 2020	SELL	$6.63 - $11.16 $110,018 - $185,189	-16,594 Reduced 61.37%	10,446 $101,000
Q4 2019 Feb 12, 2020	BUY	$7.48 - $10.75 $90,530 - $130,107	12,103 Added 81.03%	27,040 $258,000
Q2 2019 Aug 20, 2019	SELL	$10.96 - $14.4 $135,366 - $177,854	-12,351 Reduced 45.26%	14,937 $186,000
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $6,435 - $8,922	641 Added 2.41%	27,288 $371,000
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $15,368 - $24,648	-1,834 Reduced 6.44%	26,647 $246,000
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $147,250 - $209,958	-12,694 Reduced 30.83%	28,481 $344,000
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $273,424 - $340,191	19,871 Added 93.27%	41,175 $619,000
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $34,289 - $44,513	2,741 Added 14.77%	21,304 $307,000
Q3 2017 Nov 15, 2017	BUY	$11.74 - $15.78 $217,929 - $292,924	18,563	18,563 $280,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Amicus Therapeutics, Inc. Transaction History